Redox-sensitive cross-linking enhances albumin nanoparticle function as delivery system for photodynamic cancer therapy.
暂无分享,去创建一个
Anna M. Molina | Kai Griebenow | K. Griebenow | Moraima Morales-Cruz | Anna M Molina | Marimar Benítez | Kiara Berríos | Cindy M Figueroa | Marimar Benitez | Cindy M. Figueroa | Kiara N. Berríos | Moraima Morales‐Cruz
[1] J. Pellois,et al. Photodamage of lipid bilayers by irradiation of a fluorescently labeled cell-penetrating peptide. , 2014, Biochimica et biophysica acta.
[2] A. Dube,et al. Photodynamic efficacy of chlorin p6: a pH dependent study in aqueous and lipid environment. , 2008, Journal of photochemistry and photobiology. B, Biology.
[3] Ick Chan Kwon,et al. Comparative study of photosensitizer loaded and conjugated glycol chitosan nanoparticles for cancer therapy. , 2011, Journal of controlled release : official journal of the Controlled Release Society.
[4] A. Habeeb,et al. Determination of free amino groups in proteins by trinitrobenzenesulfonic acid. , 1966, Analytical biochemistry.
[5] A J Sinskey,et al. Oxidized redox state of glutathione in the endoplasmic reticulum. , 1992, Science.
[6] Vladimir Torchilin,et al. Tumor delivery of macromolecular drugs based on the EPR effect. , 2011, Advanced drug delivery reviews.
[7] Xingping Zhou,et al. Magnetic chitosan nanoparticles as a drug delivery system for targeting photodynamic therapy , 2009, Nanotechnology.
[8] Anna M. Molina,et al. Activation of caspase-dependent apoptosis by intracellular delivery of cytochrome c-based nanoparticles , 2014, Journal of Nanobiotechnology.
[9] H von Briesen,et al. Optimization of the preparation process for human serum albumin (HSA) nanoparticles. , 2003, International journal of pharmaceutics.
[10] Sarah A Heerboth,et al. Drug Resistance in Cancer: An Overview , 2014, Cancers.
[11] J. Brash,et al. X-ray microscopy studies of protein adsorption on a phase segregated polystyrene/polymethylmethacrylate surface. 2. Effect of pH on site preference. , 2008, The journal of physical chemistry. B.
[12] V. Vogel,et al. Human serum albumin (HSA) nanoparticles: reproducibility of preparation process and kinetics of enzymatic degradation. , 2008, International journal of pharmaceutics.
[13] H. Maeda. Macromolecular therapeutics in cancer treatment: the EPR effect and beyond. , 2012, Journal of controlled release : official journal of the Controlled Release Society.
[14] D. Perrier,et al. Analysis of albumin microsphere preparation , 1984 .
[15] R. Allison. Photodynamic therapy: oncologic horizons. , 2014, Future oncology.
[16] Matthias Wacker,et al. Photosensitizer loaded HSA nanoparticles. I: Preparation and photophysical properties. , 2010, International journal of pharmaceutics.
[17] Matthias G. Wacker,et al. Photosensitizer loaded HSA nanoparticles II: in vitro investigations. , 2011, International journal of pharmaceutics.
[18] Photodynamic responsiveness of human leukemia Jurkat/A4 cells with multidrug resistant phenotype. , 2014, Experimental oncology.
[19] Véronique Préat,et al. To exploit the tumor microenvironment: Passive and active tumor targeting of nanocarriers for anti-cancer drug delivery. , 2010, Journal of controlled release : official journal of the Controlled Release Society.
[20] Felix Kratz,et al. Albumin as a drug carrier: design of prodrugs, drug conjugates and nanoparticles. , 2008, Journal of controlled release : official journal of the Controlled Release Society.
[21] Anthony W. Parker,et al. Time-resolved fluorescence imaging of photosensitiser distributions in mammalian cells using a picosecond laser line-scanning microscope , 2001 .
[22] D. Hanahan,et al. Hallmarks of Cancer: The Next Generation , 2011, Cell.
[23] M. Kuroki,et al. Tumor-targeted photodynamic therapy. , 2013, Anticancer research.
[24] M. DeRosa. Photosensitized singlet oxygen and its applications , 2002 .
[25] A. Coombes,et al. Preparation of sub-100 nm human serum albumin nanospheres using a pH-coacervation method. , 1993, Journal of drug targeting.
[26] Zheng Huang,et al. Photodynamic Therapy for Treatment of Solid Tumors — Potential and Technical Challenges , 2008, Technology in cancer research & treatment.
[27] Khaled Greish,et al. Enhanced permeability and retention (EPR) effect for anticancer nanomedicine drug targeting. , 2010, Methods in molecular biology.
[28] Hans Leuenberger,et al. Albumin Nanospheres as Carriers for Passive Drug Targeting: An Optimized Manufacturing Technique , 2004, Pharmaceutical Research.
[29] I. Kraljić,et al. A NEW METHOD FOR THE DETECTION OF SINGLET OXYGEN IN AQUEOUS SOLUTIONS , 1978 .
[30] Daniel A. Heller,et al. Treating metastatic cancer with nanotechnology , 2011, Nature Reviews Cancer.
[31] R. Boyle,et al. Photodynamic therapy: novel third‐generation photosensitizers one step closer? , 2008, British journal of pharmacology.
[32] Indrajit Roy,et al. In vivo biodistribution and clearance studies using multimodal organically modified silica nanoparticles. , 2010, ACS nano.
[33] C H Sibata,et al. Bio-nanotechnology and photodynamic therapy--state of the art review. , 2008, Photodiagnosis and photodynamic therapy.
[34] D. Nowis,et al. Light and Light Sources for Pdt Direct Tumor Damage Mechanisms of Photodynamic Therapy , 2005 .
[35] S. Hackbarth,et al. Novel photosensitizer-protein nanoparticles for photodynamic therapy: photophysical characterization and in vitro investigations. , 2009, Journal of photochemistry and photobiology. B, Biology.
[36] R. Gurny,et al. Quenching-induced deactivation of photosensitizer by nanoencapsulation to improve phototherapy of cancer , 2009, Journal of drug targeting.
[37] J. Kulbacka,et al. Polymeric micelles for enhanced Photofrin II ® delivery, cytotoxicity and pro-apoptotic activity in human breast and ovarian cancer cells. , 2014, Photodiagnosis and photodynamic therapy.
[38] J. Spikes. Chlorins as photosensitizers in biology and medicine. , 1990 .